Endometrial Cancer
D6900C00003: A Phase III, Randomized, Open Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7 H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti PD 1/Anti PD L1 Therapy (BLUESTAR Endometrial01)
- Details
ClinicalTrials.gov ID:
NCT07044336
Diagnosis Type:
NA
USOR Number:
- Address
,
P: